Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Neuregulin and ErbB: Glimpses at How Glia Maintain Adult Peripheral Nervous System
5 November 2003. Though neurons are the obvious stars of the nervous system, glia are getting more attention lately as research uncovers their importance in keeping the CNS disease-free (see ARF related news story). Now, Gabriel Corfas and colleagues at Children's Hospital, Boston, report in the November Nature Neuroscience that non-myelinating Schwann cells (NMSC) are essential for a healthy adult peripheral nervous system, and that this interaction is driven in part by neuregulins released from the neuron.

The neuregulins are a complex family of growth factors (Falls, 2003). Neuregulin-1, in particular, has gained notoriety as a possible risk factor for schizophrenia Stefansson et al., 2002; Williams et al., 2003). In this study, joint first authors Suzhen Chen and Carlos Rio probed the role of neuregulin-1 in adult mice. They introduced a dominant-negative mutant of ErbB, the non-myelinating Schwann cell receptor for neuregulin. To ensure that the signaling pathway was only suppressed in adult animals, they placed the suppressor under control of the promoter for glial acid fibrillary protein; expression of the latter only reaches significant levels in the adult. ErbB is known to be essential for development of the peripheral nervous system, but its role in the developed PNS has never been elucidated.

When Chen and colleagues examined adult mice harboring the ErbB suppressor, they found that NMSCs were undergoing rampant proliferation. This in itself was a surprise because inhibition of the neuregulin pathway would be predicted to have the opposite effect. But in addition, the authors found that NMSCs were undergoing apoptosis, suggesting that blocking the pathway caused both proliferation and cell death. The mice also showed a gradual loss of sensory perception when tested for response to heat and cold. By five weeks, the animals were at least six times slower than normal animals in reaction to a heat stimulus, and twice as slow in response to cold. To understand this better the authors looked at the morphology of postganglionic axons, finding that the Remak bundles, those clusters of non-myelinated axons wrapped by a single NMSC, were completely disrupted. Furthermore, transgenic animals had about 30 percent fewer small fiber neurons than did wild type.

The findings indicate that cross-talk between NMSCs and neurons is crucial for maintaining the peripheral nervous system. Support for this comes from the fact that Chen found levels of glial-derived growth factor, which is normally released by the NMSCs and taken up by neurons, are almost three times lower in the transgenic animals. This also suggest that in diseases resulting in loss of peripheral sensory perception, for example, diabetes and Fabry's disease, there may be a glial component to pathogenesis.—Tom Fagan

Reference:
Chen S, Rio C, Ji R-R, KIkkes P, Coggeshall RE, Woolf CJ, Corfas G. Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss. Nat. Neurosci. November 2003;6:1186-1193. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad